Apoptosis(凋亡)
As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.
Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.
Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.
Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.
Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.
Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.
One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.
p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9).
Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.
References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.
Products for Apoptosis
- Caspase(99)
- 14.3.3 Proteins(1)
- Apoptosis Inducers(43)
- Bax(7)
- Bcl-2 Family(120)
- Bcl-xL(8)
- c-RET(9)
- IAP(27)
- KEAP1-Nrf2(66)
- MDM2(12)
- p53(123)
- PC-PLC(4)
- PKD(7)
- RasGAP (Ras- P21)(1)
- Survivin(8)
- Thymidylate Synthase(10)
- TNF-α(145)
- Other Apoptosis(883)
- APC(6)
- PD-1/PD-L1 interaction(90)
- ASK1(3)
- PAR4(2)
- RIP kinase(52)
- FKBP(20)
- Pyroptosis(31)
- Cat.No. 产品名称 Information
-
GC43643
Eupenifeldin
A cytotoxic fungal metabolite
-
GC43625
Erucin
芥酸精; 甘油三芥酸酯
An isothiocyanate with neuroprotective and antioxidant effects -
GC43610
Enniatin A1
恩镰孢菌素 A1
An ionophore antibiotic -
GC43606
Endothelin-1 (human, porcine) (trifluoroacetate salt)
ET-1
A peptide vasoconstrictor -
GC43565
Doxorubicinol (hydrochloride)
13-Dihydroadriamycin hydrochloride
A doxorubicin metabolite -
GC43515
D-myo-Inositol-1,3,4,5,6-pentaphosphate (sodium salt)
Ins(1,3,4,5,6)P5, 1,3,4,5,6IP5
An anticancer inositol phosphate -
GC43514
D-myo-Inositol-1,3,4,5,6-pentaphosphate (ammonium salt)
Ins(1,3,4,5,6)P5, 1,3,4,5,6IP5 (sodium salt)
An anticancer inositol phosphate -
GC43463
DiIC1(5)
1,1',3,3,3',3'-六甲基吲哚双碳菁碘
A signal-off fluorescent probe -
GC43462
Dihydrolipoic Acid
(+/-)-二氢硫辛酸,DHLA
A reduced form of α-lipoic acid -
GC43452
Diffractaic Acid
地弗地衣酸
A lichen metabolite with diverse biological activities -
GC43439
Diallyl Trisulfide
二烯丙基三硫化物
A natural H2S donor -
GC43436
Diacetylcercosporin
A perylenequinone that has diverse biological activities
-
GC43408
Deoxycholic Acid (sodium salt hydrate)
一水脱氧胆酸钠,Cholanoic Acid sodium hydrate; Desoxycholic acid sodium hydrate
A secondary bile acid -
GC43406
Delphinidin (chloride)
氯化花翠素
Natural vasorelaxant and inhibitor of EGFRs and HATs -
GC43379
Darinaparsin
Dimethylarsinic glutathione
A dimethylated arsenic linked to glutathione with anticancer activities -
GC43368
D,L-1′-Acetoxychavicol Acetate
D,L-1\'-乙酰氧基胡椒酚乙酸酯
A natural exportin 1 inhibitor -
GC43361
Cytostatin (sodium salt)
A selective PP2A inhibitor
-
GC43357
CytoCalcein™ Violet 500
A fluorogenic dye
-
GC43356
CytoCalcein™ Violet 450
A fluorogenic dye
-
GC43346
Cyclopamine-KAAD
3-酮-N-氨基乙基-N'-氨基己酰二氢肉桂酰环杷明,Cyclopamine-KAAD
A potent inhibitor of hedgehog signaling -
GC43326
CRT0066101 (hydrochloride)
Protein kinase D (PKD) is a serine/threonine protein kinase that is activated by diacylglycerol, commonly downstream of PKC signaling.
-
GC43321
CPTH6 (hydrobromide)
A Gcn5 and pCAF HAT inhibitor
-
GC43297
Coenzyme Q2
辅酶Q2
A biosynthetic precursor to CoQ10 and an inhibitor of mitochondrial complex I -
GC43274
Citromycetin
柠檬菌素
A fungal metabolite -
GC43273
Citreoindole
A diketopiperazine metabolite
-
GC43239
Chk2 Inhibitor
SC-203885
A Chk2 inhibitor -
GC43237
Chevalone C
A fungal metabolite
-
GC43236
Chevalone B
A fungal metabolite
-
GC43234
Chaetoglobosin A
球毛壳菌素 A
A mycotoxic cytochalasin -
GC43230
Ceramides (non-hydroxy)
Ceramides are generated from sphingomyelin through activation of sphingomyelinases or through the de novo synthesis pathway, which requires the coordinated action of serine palmitoyl transferase and ceramide synthase.
-
GC43229
Ceramide Phosphoethanolamines (bovine)
Ceramide phosphoethanolamine (CPE) is an analog of sphingomyelin that contains ethanolamine rather than choline as the head group.
-
GC43217
CDK/CRK Inhibitor
Cdk7 Inhibitor IV, Cyclin-dependent kinase 7 Inhibitor IV, Cyclin-dependent kinase/CDK-related kinase Inhibitor, RGB-286147
A CDK/CRK-specific kinase inhibitor -
GC43203
CAY10726
An arylurea fatty acid
-
GC43198
CAY10717
A multi-targeted kinase inhibitor
-
GC43190
CAY10682
A dual inhibitor of p53-Mdm2 interaction and NF-κB signaling
-
GC43189
CAY10681
A dual modulator of p53-MDM2 interaction and NF-κB signaling
-
GC43176
CAY10575
IKK2 Inhibitor 3, Polo-like Kinase Inhibitor 1
An IKKβ and Plk1 inhibitor -
GC43154
CAY10443
(S)Indan1yl 3,4dichlorobenzylcarbamate
A cytochrome c-dependent inducer of apoptosis -
GC43150
CAY10406
A trifluoromethyl analog of a selective caspase inhibitor
-
GC43149
CAY10404
A COX-2 inhibitor
-
GC43146
Caspase-9 Inhibitor III (trifluoroacetate salt)
Ac-LEHD-CMK
A caspase-9 inhibitor -
GC43144
Carfilzomib Impurity 13 (hydrochloride)
A potential impurity found in commercial carfilzomib preparations
-
GC43125
Calcein UltraBlue™ AM
Calcein UltraBlue Acetoxymethyl ester
A fluorogenic dye -
GC43123
Calcein Red™ AM
Calcein Red Acetoxymethyl ester
A fluorogenic dye -
GC43121
Calcein Orange™ Diacetate
A fluorogenic dye
-
GC43111
C8 L-threo Ceramide (d18:1/8:0)
L-threo Cer(d18:1/8:0), L-threo Ceramide (d18:1/8:0), N-octanoyl-L-threo-Sphingosine
A bioactive sphingolipid -
GC43110
C8 Galactosylceramide (d18:1/8:0)
Galactosylceramide (d18:1/8:0), N-octanoyl-βD-Galactosylceramide, GalCer(d18:1/8:0)
A synthetic bioactive sphingolipid -
GC43109
C8 D-threo Ceramide (d18:1/8:0)
D-threo Cer(d18:1/8:0), D-threo Ceramide (d18:1/8:0), N-octanoyl-D-threo-Sphingosine
A bioactive sphingolipid -
GC43105
C8 Ceramide (d18:1.8:0)
N-辛酰基-D-神经鞘氨醇; N-Octanoyl-D-erythro-sphingosine
A cell-permeable ceramide analog -
GC43084
C4 Ceramide (d18:1/4:0)
C4酰胺,Cer(d18:1/4:0)
A bioactive sphingolipid